Table 1.

Population Summary of the Progressed and Nonprogressed Patient Datasets from the UCSD Diagnostic Innovations in Glaucoma Study

	DIGS Eyes Progressed by Disc and/or GPA	DIGS Eyes Progressed by Disc	DIGS Eyes Nonprogressed
Eyes (n)	36	20	210
Subjects (n)	33	20	148
Age (y), mean (95% CI)	70.37 (67.26–73.48)	67.65 (63.99–71.31)	66.24 (64.24–68.24)
HRT exams (n), median (range)	5 (4–8)	5 (4–8)	4 (4–8)
HRT follow-up (y), median (range)	4.13 (2.38–6.96)	4.36 (2.38–6.96)	3.59 (1.65–7.40)
SAP MD at baseline (dB), mean (95% CI)	−3.65 (−5.45–−1.84)	−4.34 (−7.35–−1.33)	−1.72 (−2.16–−1.28)
SAP PSD at baseline (dB), mean (95% CI)	4.19 (2.87–5.51)	5.32 (3.10–7.54)	2.47 (2.18–2.76)
Abnormal disc by photography only at baseline, n (%)	12 (33.3)	6 (30.0)	54 (25.7)
Abnormal visual field only at baseline, n (%)	4 (11.1)	1 (5.0)	28 (13.33)
Abnormal disc and abnormal visual field at baseline, n (%)	15 (41.7)	9 (45.0)	41 (19.52)
Normal disc and normal visual field at baseline, n (%)	5 (13.9)	4 (20.0)	87 (41.43)